Participants 92 148 7
patients with standard-risk acute lymphoblastic leukemia
Participants 219 265 3
childhood acute lymphoblastic leukemia (ALL) i
Participants 478 616 7
We report the results of a randomized trial of more than 1000 subjects that examined the efficacy of dexamethasone and IV 6-mercaptopurine
Participants 618 698 6
Children with National Cancer Institute standard-risk ALL were randomly assigned
